MRI-SWI as a Predictor of Functional Outcome in Acute Ischemic Stroke
NCT ID: NCT00696306
Last Updated: 2011-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2008-02-29
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between TOF and SWAN Sequences in the Detection of Arterial Occlusion in Acute Ischemic Stroke Using MRI
NCT03645902
A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients
NCT02024503
Prognosis in Subacute Ischemic Stroke Using Multimodal Imaging
NCT06289036
The Correlation Between Outcome and Infarct Growth in Patients With Acute Ischemic Stroke
NCT01376609
Screening of Endovascular Thrombectomy With MRI in Acute Ischemic Stroke
NCT06213870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diffusion tensor imaging (DTI) characterizes the three-dimensional distribution of water diffusion, which is highly anisotropic. Previous studies utilized DTI derived mean diffusivity (MD) and fractional anisotropy (FA) have found correlation between pathological changes of white matter and prognosis of stroke. However, the result was not specific due to the reason that any change at either axon or myelin sheath resulted in FA reduction. DTI, on the other hand, differentiate morphological change at axon and myelin sheath with axial and radial diffusivity, respectively. With this data, we hypothesized that the prognosis might be more relevant to pathological change with axon post-stroke when compare to Diffusion-Weighted imaging (DWI)/Apparent Diffusion Coefficient (ADC).
Susceptibility-weighted imaging (SWI) is a newer technique which use fully velocity compensation gradient echo sequence to receive magnitude and phase imaging. SWI can be used to detect early phase bleed, intra-arterial thrombus, cerebral venous thrombosis, thus evaluate the prognosis of patients by detect leptomeningeal collateral circulation and intravascular deoxygenation changes. We hypothesized that the prognosis is better in post-stroke patients with preserved leptomeningeal collateral circulation and venous circulation of large blood vessel. Therefore, we conduct the study to use DTI derived axial diffusivity and SWI to evaluate the severity and to predict the functional outcome in acute ischemic stroke patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with acute pathological changes in CNS within 7 days admitted from outpatient, ER, or inpatient department
* Confirmed diagnosis of acute ischemic stroke by clinical testings and CT scan performed by a neurologist
* Signed informed consent from patient
Exclusion Criteria
* Any person with epilepsy, brain hematomas, brain tumor, or any neurological disease confirmed by CT scan
* Any other clinical condition which, in the opinion of the principal investigator, would not be suitable for this study
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taipei Medical University-Wan Fang Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chin-I Chen, MD
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University-Wan Fang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University-Wan Fang Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007WFCRC-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.